The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study

Autor: Serra-Burriel, Miquel, Perényi, Gellért, Laube, Yannic, Mitchell, Aaron P., Vokinger, Kerstin N.
Zdroj: In eClinicalMedicine July 2023 61
Databáze: ScienceDirect